SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-030570
Filing Date
2021-02-05
Accepted
2021-02-05 16:21:48
Documents
99
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d123013d6k.htm   iXBRL 6-K 260946
2 EX-99.1 d123013dex991.htm   iXBRL EX-99.1 1532695
3 EX-99.2 d123013dex992.htm EX-99.2 401113
  Complete submission text file 0001193125-21-030570.txt   10997349

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA imab-20200930.xsd EX-101.SCH 89296
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imab-20200930_cal.xml EX-101.CAL 50598
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imab-20200930_def.xml EX-101.DEF 466081
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE imab-20200930_lab.xml EX-101.LAB 638499
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imab-20200930_pre.xml EX-101.PRE 591924
9 EXTRACTED XBRL INSTANCE DOCUMENT d123013d6k_htm.xml XML 1980958
Mailing Address SUITE 802, WEST TOWER, OMNLVISION 88 SHANGKE ROAD, PUDONG DISTRICT SHANGHAI F4 201210
Business Address SUITE 802, WEST TOWER, OMNLVISION 88 SHANGKE ROAD, PUDONG DISTRICT SHANGHAI F4 201210 862160578000
I-Mab (Filer) CIK: 0001778016 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39173 | Film No.: 21595695
SIC: 2834 Pharmaceutical Preparations